Catalyst Wire Dossier Catalyst Wire Dossier

Levofloxacin Ophthalmic Solution 1.5%

levofloxacin · Santen Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Levofloxacin Ophthalmic Solution 1.5%, covering 2009-02-06 to 2009-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery [Phase 4]

See pricing